Literature DB >> 8623910

The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization.

S C Goldman1, C Y Chen, T J Lansing, T M Gilmer, M B Kastan.   

Abstract

Mutations of the p53 tumor suppressor gene are rarely found in neuroblastoma. Though typically a nuclear protein, a number of tumor cell types have recently been reported to exhibit cytoplasmic p53 immunostaining, and it has been suggested that altered cellular localization is another mechanism of inhibiting p53 function. We examined p53 protein expression, localization, and function in neuroblastoma cell lines with wild-type p53 genes. Basal p53 levels were largely confined to the cytoplasmic compartment in these cells. However, after irradiation, p53 protein levels increased predominately in the nucleus. Transcriptional activity of p53 was intact in these cells because "downstream" proteins, p21WAF1 and MDM2, were induced by irradiation. In contrast to a neuroblastoma cell line harboring a mutant p53 gene, the neuroblastoma cells with wild-type protein were associated with an intact G1 arrest after DNA damage. The induced nuclear protein in these neuroblastoma cells also appeared functional as measured by its capacity to bind to a DNA oligomer containing a p53-consensus sequence. We have concluded that although p53 expression in neuroblastoma cells is primarily localized to the cytosol, ionizing radiation induces a functional p53 protein in the nucleus and that this cytoplasmic sequestration of p53 in human neuroblastoma is not a mechanism of inactivating p53 function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623910      PMCID: PMC1861565     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  14 in total

1.  No TP53 mutations in neuroblastomas detected by PCR-SSCP analysis.

Authors:  J S Castresana; M J Bello; J A Rey; P Nebreda; A Queizán; P García-Miguel; A Pestaña
Journal:  Genes Chromosomes Cancer       Date:  1994-06       Impact factor: 5.006

2.  Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells.

Authors:  R W Craig; H L Buchan; C I Civin; M B Kastan
Journal:  Cell Growth Differ       Date:  1993-05

3.  Low frequency of the p53 gene mutations in neuroblastoma.

Authors:  G Hosoi; J Hara; T Okamura; Y Osugi; S Ishihara; M Fukuzawa; A Okada; S Okada; A Tawa
Journal:  Cancer       Date:  1994-06-15       Impact factor: 6.860

4.  Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

Authors:  U M Moll; G Riou; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 5.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

6.  Absence of p53 gene mutations in primary neuroblastomas.

Authors:  K Vogan; M Bernstein; J M Leclerc; L Brisson; J Brossard; G M Brodeur; J Pelletier; P Gros
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

7.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Levels of p53 protein increase with maturation in human hematopoietic cells.

Authors:  M B Kastan; A I Radin; S J Kuerbitz; O Onyekwere; C A Wolkow; C I Civin; K D Stone; T Woo; Y Ravindranath; R W Craig
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

Review 9.  P53, cell cycle control and apoptosis: implications for cancer.

Authors:  M B Kastan; C E Canman; C J Leonard
Journal:  Cancer Metastasis Rev       Date:  1995-03       Impact factor: 9.264

10.  p53-dependent apoptosis suppresses tumor growth and progression in vivo.

Authors:  H Symonds; L Krall; L Remington; M Saenz-Robles; S Lowe; T Jacks; T Van Dyke
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

View more
  25 in total

1.  N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons.

Authors:  Kirmo Wartiovaara; Fanie Barnabe-Heider; Freda D Miller; David R Kaplan
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation.

Authors:  Ryo Maeda; Hiroyuki Tamashiro; Kazunori Takano; Hiro Takahashi; Hidefumi Suzuki; Shinta Saito; Waka Kojima; Noritaka Adachi; Kiyoe Ura; Takeshi Endo; Taka-Aki Tamura
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

3.  Genetic analysis of p53 nuclear importation.

Authors:  Q Li; R R Falsey; S Gaitonde; V Sotello; K Kislin; J D Martinez
Journal:  Oncogene       Date:  2007-06-18       Impact factor: 9.867

Review 4.  Therapeutic targets for neuroblastomas.

Authors:  Garrett M Brodeur; Radhika Iyer; Jamie L Croucher; Tiangang Zhuang; Mayumi Higashi; Venkatadri Kolla
Journal:  Expert Opin Ther Targets       Date:  2014-01-06       Impact factor: 6.902

5.  Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide.

Authors:  A G Ostermeyer; E Runko; B Winkfield; B Ahn; U M Moll
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

6.  p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells.

Authors:  D A Tweddle; A J Malcolm; M Cole; A D Pearson; J Lunec
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

7.  P53 is transported into the nucleus via an Hsf1-dependent nuclear localization mechanism.

Authors:  Qiang Li; Jesse D Martinez
Journal:  Mol Carcinog       Date:  2010-12-10       Impact factor: 4.784

8.  Loss of HSF1 results in defective radiation-induced G(2) arrest and DNA repair.

Authors:  Qiang Li; Jesse D Martinez
Journal:  Radiat Res       Date:  2011-05-10       Impact factor: 2.841

9.  Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells.

Authors:  Ze Tian; Ning An; Bin Zhou; Peigen Xiao; Isaac S Kohane; Erxi Wu
Journal:  Cancer Chemother Pharmacol       Date:  2008-10-03       Impact factor: 3.333

10.  Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma.

Authors:  Dana-Lynn T Koomoa; Tamas Borsics; David J Feith; Craig C Coleman; Christopher J Wallick; Ivonne Gamper; Anthony E Pegg; André S Bachmann
Journal:  Mol Cancer Ther       Date:  2009-07-07       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.